Close Menu

Leukemia and Lymphoma Society

The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis. 

The Leukemia and Lymphoma Society grant will fund genome-wide analysis research.

NHGRI's rare diseases program will partner with The University of Kansas and the Leukemia and Lymphoma Society to speed up therapeutic development.

LLS will select ten small molecule candidates deemed to have the best chance of quickly advancing to clinical trials from its portfolio of grant-funded academic research projects, and Forma will use its computational solvent mapping technology to ready the molecules for the clinic.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.